XML 31 R89.htm IDEA: XBRL DOCUMENT v2.4.0.8
SHARE-BASED COMPENSATION (Details 2) (USD $)
 12 Months Ended 1 Months Ended 12 Months Ended 12 Months Ended
Dec. 31, 2013
Dec. 31, 2011
Dec. 31, 2013
2013 Plan
Dec. 31, 2013
Equity Incentive
Dec. 31, 2012
Equity Incentive
Dec. 31, 2011
Equity Incentive
Apr. 30, 1997
Equity Incentive
1997 Plan
May 31, 2007
Equity Incentive
2004 Plan
Dec. 31, 2013
Equity Incentive
2004 Plan
Dec. 31, 2012
Equity Incentive
2004 Plan
Dec. 31, 2011
Equity Incentive
2004 Plan
Apr. 30, 2011
Equity Incentive
2004 Plan
Mar. 31, 2011
Equity Incentive
2004 Plan
Sep. 30, 2004
Equity Incentive
2004 Plan
Apr. 30, 2013
Equity Incentive
2013 Plan
Dec. 31, 2013
Equity Incentive
Minimum
Dec. 31, 2013
Equity Incentive
Maximum
SHARE-BASED COMPENSATION                                  
Vesting period                               3 years 5 years
Contractual terms       10 years                          
Shares authorized for grants             2,000,000         4,944,831 1,402,589 1,500,000 2,200,000    
Additional shares authorized for grants               1,000,000                  
Weighted-average assumptions used in estimating the fair value of the stock options granted to employees                                  
Expected volatility (as a percent)         77.20%                        
Risk free interest rate (as a percent)         1.80%                        
Expected dividends (as a percent)         1.00%                        
Expected life         8 years                        
Weighted average fair value (in dollars per share)         $ 9.65                        
Shares                                  
Outstanding at the beginning of the period (in shares)       315,369,000                          
Changes during the period                                  
Granted (in shares) 0 0             2,185,454 1,604,198 2,539,341            
Exercised (in shares)       (5,186,000) 0 0                      
Expired (in shares)       (7,024,000)                          
Forfeited (in shares)       (511,000)                          
Outstanding at the end of the period (in shares)       302,648,000 315,369,000                        
Vested and expected to vest at the end of the period (in shares)       302,648,000                          
Exercisable at the end of the period (in shares)       91,241,000                          
Weighted Average Exercise Price                                  
Outstanding at the beginning of the period (in dollars per share)       $ 62.77                          
Changes during the period:                                  
Exercised (in dollars per share)       $ 14.31                          
Expired (in dollars per share)       $ 539.38                          
Forfeited (in dollars per share)       $ 508.11                          
Outstanding at the end of the period (in dollars per share)       $ 51.79 $ 62.77                        
Vested and expected to vest at the end of the period (in dollars per share)       $ 51.79                          
Exercisable at the end of the period (in dollars per share)       $ 138.56                          
Weighted Average Remaining Contractual Term                                  
Outstanding at the end of the period       7 years 10 months 24 days                          
Vested and expected to vest at the end of the period       7 years 10 months 24 days                          
Exercisable at the end of the period       6 years 9 months 18 days                          
Aggregate Intrinsic Value                                  
Outstanding at the end of the period (in dollars)       $ 1,598,000                          
Vested and expected to vest at the end of the period (in dollars)       1,598,000                          
Exercisable at the end of the period (in dollars)       384,000                          
Additional disclosures                                  
Aggregate intrinsic value of options exercised     22,000                            
Total compensation cost not yet recognized (in dollars)       1,600,000                          
Weighted-average period for recognition of compensation cost not yet recognized       3 years 2 months 12 days                          
Total fair value of shares vested (in dollars)       $ 700,000 $ 14,000 $ 17,000